Skip to main content
. 2012 Aug 6;30(26):3194–3201. doi: 10.1200/JCO.2012.41.7071

Fig 3.

Fig 3.

(A) Cumulative incidence of leukemia relapse by treatment arm. (B) Cumulative incidence of nonrelapse mortality by treatment arm. (C) Probability of disease-free survival by treatment arm. (D) Probability of overall survival by treatment arm. (E) Probability of graft-versus host disease–free survival by treatment arm. IST, immune suppression therapy; TCD, T-cell depletion.